Skip to main content
. 2018 Feb 5;15(4):3336–3344. doi: 10.3892/etm.2018.5835

Table V.

General description of the treatment of patients with inflammatory bowel disease.

Treatment/item Ulcerative colitis Crohn's disease
Current treatment
  5-ASA 15 2
  5-ASA + Azathioprine   5 7
  5-ASA + Adalimumab   3 2
Use of anti-TNF-α in the course of the disease
  Yes   5 2
  No 15 7
Change in anti-TNF-α regimen
  Maintenance treatment   3 2
  Failure   2 1
  Allergic reaction   1 0
  Restart treatment due to relapse   2 0
Azathioprine intolerance   0 1

5-ASA, 5-aminosalicylic acid; TNF, tumor necrosis factor.